Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H46O8 |
Molecular Weight | 534.6814 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](CC[C@]34O)C5=CC(=O)OC5)[C@@]1(C)CC[C@@H](C2)O[C@]6([H])O[C@@H](C)[C@H](O)[C@@H](OC)[C@@H]6O
InChI
InChIKey=VPUNMTHWNSJUOG-BAOINKAISA-N
InChI=1S/C30H46O8/c1-16-24(32)26(35-4)25(33)27(37-16)38-19-7-10-28(2)18(14-19)5-6-22-21(28)8-11-29(3)20(9-12-30(22,29)34)17-13-23(31)36-15-17/h13,16,18-22,24-27,32-34H,5-12,14-15H2,1-4H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28-,29+,30-/m0/s1
Molecular Formula | C30H46O8 |
Molecular Weight | 534.6814 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25075041Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21459134 | https://www.ncbi.nlm.nih.gov/pubmed/20438743 | https://www.ncbi.nlm.nih.gov/pubmed/16793926
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25075041
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21459134 | https://www.ncbi.nlm.nih.gov/pubmed/20438743 | https://www.ncbi.nlm.nih.gov/pubmed/16793926
Neriifolin is a cardenolide glycoside that is digitoxigenin in which the hydroxy goup at position 3 has been converted to its 6-deoxy-3-O-methyl-alpha-L-glucopyranoside derivative. Found in the seeds of Cerbera odollamand in Thevetia ahouia and Thevitia neriifolia. Neriifolin reduced viability of cancer cells, induced S and G2/M phase arrests of the cell cycle, and stimulated apoptosis.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095186 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1966653 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Management of yellow oleander poisoning. | 2009 Mar |
|
Double lethal coconut crab (Birgus latro L.) poisoning. | 2010 Jan |
|
A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. | 2010 Sep 1 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16793926
Pilot studies determined that up to 3 mg/kg neriifolin could be given i.v. without substantive changes in arterial blood pressure. Rats were then randomly assigned to receive vehicle (10% acetic acid) or neriifolin (0.75 mg/kg or 1.5 mg/kg i.v.) at middle cerebral artery occlusion (MCAO) onset. Cerebral infarct sizes measured at 24 h after MCAO were reduced in a dose-dependent manner by neriifolin
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25075041
The SKOV-3 ovarian cancer cells were treated with 0.01 mkM 17βH-neriifolin respectively, for 4, 6, 12 and 24 hours prior to terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Another set of experiment was also conducted to study the effect of different concentrations of 17βH-neriifolin (0.001, 0.01, 0.1 μM) incubated for 24 hours. Results from TUNEL assay indicated that 17βH-neriifolin caused apoptosis in SKOV-3 cells in a dose-dependent manner.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:57:17 GMT 2023
by
admin
on
Sat Dec 16 07:57:17 GMT 2023
|
Record UNII |
5RD2ADS9WV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
207-372-5
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
123976
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
m7829
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
7522
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
441867
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
DTXSID40881390
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
466-07-9
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY | |||
|
5RD2ADS9WV
Created by
admin on Sat Dec 16 07:57:17 GMT 2023 , Edited by admin on Sat Dec 16 07:57:17 GMT 2023
|
PRIMARY |